Share
HKEX
867
China Medical System Holdings Ltd.
HKD 10.2900
0.0900 (+0.8824%)
Last updated: 20 Oct 2026 9:34:18 AM
DelayedDelayed at least 15 minutes
Last updated: 20 Oct 2026 9:34:18 AM (Singapore Time)
HKEX867
China Medical System Holdings Ltd.
DelayedDelayed at least 15 minutes
HKD 10.2900
+0.8824%
+ HKD 0.0900
Open
HKD 10.2100
Prev. Close
HKD 10.2000
Bid
HKD 10.2500
Bid Volume
1,000
Ask
HKD 10.2900
Ask Volume
14,000
Total Volume
85,000
Market Cap
HKD 24.62 Billion
Shares Outstanding
2.41 Billion
30 Days Average Volume
4.60 Million
10.1900
Day's Range
10.2900
Day's Range
10.1900
10.2900
9.5100
52 Weeks Range
15.5200
52 Weeks Range
9.5100
15.5200
Board Lot Size
1000
SHOW ALL KEY STATISTICS
867 Chart
Delayed
Chart data is delayed at least 15 minutes.
3M6M1Y3Y5Y10Y
TA Chart
Created with Highcharts 9.3.2Chart context menu20. Jul27. Jul3. Aug10. Aug17. Aug24. Aug31. Aug7. Sep14. Sep21. Sep28. Sep5. Oct12. Oct19. Oct10111213iFAST
Stock Information
Market Cap
HKD 24.62 Billion
Shares Outstanding
2.41 Billion
30 Days Average Volume
4.60 Million
Product Currency
HKD
Valuations
Earnings Per Share
HKD 0.667
Price-to-Earnings Ratio (PE)
14.432
Historical Average PE Ratio
11.868
Price-to-Book Ratio (PB)
1.187
Price-to-Sales Ratio (PS)
2.534
Price/Earnings-to-Growth Ratio
-0.411
Selected Financial Data
Free Cash Flow
HKD 1.14 Billion
Debt-to-Equity Ratio
0.001
Current Ratio
6.329
Quick Ratio
5.782
Return On Equity (%)
8.79
Return On Assets (%)
7.96
Dividend Info
Historical Annual Dividend
0.189
Forward Dividend Yield (%)
2.883
Payout Ratio (%)
48.294
Last Dividend Ex Date
28 Aug 2026
Next Dividend Ex Date
-
Financial Information
Income StatementBalance SheetCash Flow Statements
Created with Highcharts 12.6.0Chart context menuRevenueNet Income202520242023202220210.00M2.50B5.00B7.50B10.00B12.50B
(HKD)
2025 YOY Change
2024 YOY Change
2023 YOY Change
2022 YOY Change
2021 YOY Change
Revenue
8.91B
9.98%
8.10B
-8.54%
8.85B
-16.79%
10.64B
5.90%
10.05B
28.74%
Operating Income
1.71B
-4.47%
1.79B
-39.33%
2.95B
-28.59%
4.13B
8.78%
3.80B
22.30%
Net Income
1.61B
-8.06%
1.76B
-33.80%
2.65B
-30.00%
3.79B
4.21%
3.64B
27.90%
About China Medical System Holdings Ltd.
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, and MOVICOL. It operates through the Integrated Business and Skin Health Business segments. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.
Sector
Health Technology
Industry Classification
Pharmaceuticals: Major
Revenue
HKD 8.91 Billion
Market Cap
HKD 24.62 Billion
Net Income
HKD 1.61 Billion
Shares Outstanding
2.41 Billion
Fiscal Year End
31 Dec 2026
52 Weeks Range
HKD 9.5100 - HKD 15.5200
Employees
6,415
30 Days Average Volume
4.60 Million
Website
Sector
Health Technology
Industry Classification
Pharmaceuticals: Major
Revenue
HKD 8.91 Billion
Market Cap
HKD 24.62 Billion
Net Income
HKD 1.61 Billion
Shares Outstanding
2.41 Billion
Fiscal Year End
31 Dec 2026
52 Weeks Range
HKD 9.5100 - HKD 15.5200
Employees
6,415
30 Days Average Volume
4.60 Million
Website
Payment Method
Included under CashYes
Included under CPFIS OANo
Included under CPFIS SANo
Included under SRSNo
Upcoming Exchange HolidaysMORE
Hong Kong
23Dec
Eve of Christmas (Half-Day Trading)
24Dec
Christmas Day
30Dec
Eve of New Year (Half-Day Trading)
Tools
newCalculatorIcon
Stock Calculator
newCalculatorIcon
Stock Returns
newScreenerSelectorIcon
Stock Screener
newCalculatorIcon
Intrinsic Value Calculator
newGainerIcon
Top Gainer Loser